Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Allervax Cat moves towards commercialization

Jan. 8, 1997

SangStat files for U.S. marketing approval of Thymoglobulin

Jan. 7, 1997

New AIDS vaccine candidates reported by Institut Pasteur

Jan. 3, 1997

Immunomodulatory effects of ranitidine assessed in patient studies

Jan. 2, 1997

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Anti-CD2 MAb enters phase II for GVHD

Dec. 23, 1996

Autoimmune disease Rx enters clinical trials

Dec. 20, 1996

Antex to be issued patent covering H. influenzae proteins

Dec. 19, 1996

Positive results reported for group A Streptococcus vaccine

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...